Screening for and Optimal Management of Small Abdominal Aortic Aneurysms: The Quest Continues | Bentham Science
Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Screening for and Optimal Management of Small Abdominal Aortic Aneurysms: The Quest Continues

Author(s): Kosmas I. Paraskevas*, Hans-Henning Eckstein, Andrew N. Nicolaides and George Geroulakos

Volume 18, Issue 6, 2020

Page: [663 - 666] Pages: 4

DOI: 10.2174/1570161118999191126145824

Open Access Journals Promotions 2
« Previous Next »
[1]
Geroulakos G, Nicolaides A. Infrarenal abdominal aortic aneurysms less than five centimetres in diameter: the surgeon’s dilemma. Eur J Vasc Surg 1992; 6(6): 616-22.
[http://dx.doi.org/10.1016/S0950-821X(05)80838-2] [PMID: 1451817]
[2]
Paraskevas KI, Gloviczki P. Some asymptomatic abdominal aortic aneurysms smaller than 5.5 cm can be considered for elective repair. J Vasc Surg 2018; 67(6): 1645-8.
[http://dx.doi.org/10.1016/j.jvs.2018.01.042] [PMID: 29685510]
[3]
Spanos K, Eckstein HH, Giannoukas AD. Small abdominal aortic are not all the same. Angiology 2020; 71(3): 205-07.
[http://dx.doi.org/10.1177/0003319719862965] [PMID: 31315421]
[4]
Thompson SG, Ashton HA, Gao L, Buxton MJ, Scott RAP. Multicentre Aneurysm Screening Study (MASS) Group Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg 2012; 99(12): 1649-56.
[http://dx.doi.org/10.1002/bjs.8897] [PMID: 23034729]
[5]
Ashton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RA. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007; 94(6): 696-701.
[http://dx.doi.org/10.1002/bjs.5780] [PMID: 17514666]
[6]
Lindholt JS, Sørensen J, Søgaard R, Henneberg EW. Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial. Br J Surg 2010; 97(6): 826-34.
[http://dx.doi.org/10.1002/bjs.7001] [PMID: 20473995]
[7]
Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP. Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 160(5): 321-9.
[http://dx.doi.org/10.7326/M13-1844] [PMID: 24473919]
[8]
McCaul KA, Lawrence-Brown M, Dickinson JA, Norman PE. Long-term outcomes of the Western Australian trial of screening for abdominal aortic aneurysms: secondary analysis of a randomized clinical trial. JAMA Intern Med 2016; 176(12): 1761-7.
[http://dx.doi.org/10.1001/jamainternmed.2016.6633] [PMID: 27802493]
[9]
Paraskevas KI, Brennan JA. To screen, or not to screen, that is the question. Angiology 2018; 69(3): 272-3.
[http://dx.doi.org/10.1177/0003319717704324] [PMID: 28401791]
[10]
Sprynger M, Willems M, Van Damme H, Drieghe B, Wautrecht JC, Moonen M. Screening program of abdominal aortic aneurysm. Angiology 2019; 70(5): 407-13.
[http://dx.doi.org/10.1177/0003319718824940] [PMID: 30654619]
[11]
Spanos K, Labropoulos N, Giannoukas A. Abdominal aortic aneurysm screening: do we need to shift toward a targeted strategy? Angiology 2018; 69(3): 192-4.
[http://dx.doi.org/10.1177/0003319717710861] [PMID: 28539057]
[12]
Paraskevas KI, Brar R, Constantinou J, Tsui J, Baker DM. Screening programs for abdominal aortic aneurysms: luxury or necessity? Angiology 2019; 70(5): 385-7.
[http://dx.doi.org/10.1177/0003319718766740] [PMID: 29607670]
[13]
Chabok M, Nicolaides A, Aslam M, et al. Risk factors associated with increased prevalence of abdominal aortic aneurysm in women. Br J Surg 2016; 103(9): 1132-8.
[http://dx.doi.org/10.1002/bjs.10179] [PMID: 27332825]
[14]
Trenner M, Eckstein HH. Under the Radar – 30% of patients with operated ruptured abdominal aortic aneurysms (AAAs) do not qualify for AAA screening German Society of Vascular Surgery Annual Meeting, Mannheim 16-19 October 2019.
[15]
Earnshaw JJ. Final say on research into population screening for abdominal aortic aneurysm. Angiology 2018; 69(5): 365-6.
[http://dx.doi.org/10.1177/0003319717705531] [PMID: 28415849]
[16]
Takagi H, Ando T, Umemoto T. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Abdominal aortic aneurysm screening reduces all-cause mortality: make screening great again. Angiology 2018; 69(3): 205-11.
[http://dx.doi.org/10.1177/0003319717693107] [PMID: 28193091]
[17]
Johansson M, Jørgensen KJ, Brodersen J. Harms of screening for abdominal aortic aneurysm: is there more to life than a 0.46% disease-specific mortality reduction? Lancet 2016; 387(10015): 308-10.
[http://dx.doi.org/10.1016/S0140-6736(15)00472-9] [PMID: 26474807]
[18]
Paraskevas KI, Veith FJ, Mikhailidis DP. The association between abdominal aortic aneurysms with cardiovascular and noncardiovascular diseases. Angiology 2019; 70(1): 8-11.
[http://dx.doi.org/10.1177/0003319718785790] [PMID: 29976079]
[19]
Makrygiannis G, Mourmoura E, Spanos K, et al. Risk factor assessment in a greek cohort of patients with large abdominal aortic aneurysms. Angiology 2019; 70(1): 35-40.
[http://dx.doi.org/10.1177/0003319718774474] [PMID: 29739236]
[20]
Wang YD, Liu ZJ, Ren J, Xiang MX. Pharmacological therapy of abdominal aortic aneurysm: an update. Curr Vasc Pharmacol 2018; 16(2): 114-24.
[http://dx.doi.org/10.2174/1570161115666170413145705] [PMID: 28412911]
[21]
Salata K, Syed M, Hussain MA, et al. Statins reduce abdominal aortic aneurysm growth, rupture, and perioperative mortality: a systematic review and meta-analysis. J Am Heart Assoc 2018; 7(19): e008657.
[http://dx.doi.org/10.1161/JAHA.118.008657] [PMID: 30371297]
[22]
Pafili K, Gouni-Berthold I, Papanas N, Mikhailidis DP. Abdominal aortic aneurysms and diabetes mellitus. J Diabetes Complications 2015; 29(8): 1330-6.
[http://dx.doi.org/10.1016/j.jdiacomp.2015.08.011] [PMID: 26440573]
[23]
Patel K, Zafar MA, Ziganshin BA, Elefteriades JA. Diabetes mellitus: is it protective against aneurysm? A narrative review. Cardiology 2018; 141(2): 107-22.
[http://dx.doi.org/10.1159/000490373] [PMID: 30453299]
[24]
Tang W, Yao L, Hoogeveen RC, et al. The association of biomarkers of inflammation and extracellular matrix degradation with the risk of abdominal aortic aneurysm: The ARIC Study. Angiology 2019; 70(2): 130-40.
[http://dx.doi.org/10.1177/0003319718785278] [PMID: 29945457]
[25]
Tsimikas S, Willeit P, Willeit J, et al. Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. J Am Coll Cardiol 2012; 60(21): 2218-29.
[http://dx.doi.org/10.1016/j.jacc.2012.08.979] [PMID: 23122790]
[26]
Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med 2013; 273(1): 6-30.
[http://dx.doi.org/10.1111/j.1365-2796.2012.02592.x] [PMID: 22998429]
[27]
Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 2013; 61(11): 1146-56.
[http://dx.doi.org/10.1016/j.jacc.2012.12.023] [PMID: 23375930]
[28]
van Dijk RA, Kolodgie F, Ravandi A, et al. Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. J Lipid Res 2012; 53(12): 2773-90.
[http://dx.doi.org/10.1194/jlr.P030890] [PMID: 22969153]
[29]
Willeit P, Kiechl S, Kronenberg F, et al. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol 2014; 64(9): 851-60.
[http://dx.doi.org/10.1016/j.jacc.2014.03.061] [PMID: 25169167]
[30]
Kotani K, Sahebkar A, Serban MC, et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group Lipoprotein(a) levels in patients with abdominal aortic aneurysm. Angiology 2017; 68(2): 99-108.
[http://dx.doi.org/10.1177/0003319716637792] [PMID: 26980774]
[31]
Tsimikas S, Viney NJ, Hughes SG, et al. Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. Lancet 2015; 386(10002): 1472-83.
[http://dx.doi.org/10.1016/S0140-6736(15)61252-1] [PMID: 26210642]
[32]
Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018; 67(1): 2-77.
[http://dx.doi.org/10.1016/j.jvs.2017.10.044] [PMID: 29268916]
[33]
Wanhainen A, Verzini F, Van Herzeele I, et al. Esvs Guidelines Committee European society for vascular surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg 2019; 57(1): 8-93.
[http://dx.doi.org/10.1016/j.ejvs.2018.09.020] [PMID: 30528142]
[34]
Posso M, Quintana MJ, Bellmunt S, et al. GRADE-based recommendations for surgical repair of nonruptured abdominal aortic aneurysm. Angiology 2019; 70(8): 701-10.
[http://dx.doi.org/10.1177/0003319719838892] [PMID: 30961349]
[35]
Filardo G, Powell JT, Martinez MA, Ballard DJ. Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev 2015; 2(2): CD00183.
[http://dx.doi.org/10.1002/14651858.CD001835.pub4] [PMID: 25927098]
[36]
Paraskevas KI, Eckstein HH, Schermerhorn ML. Guideline recommendations for the management of abdominal aortic aneurysms. Angiology 2019; 70(8): 688-9.
[http://dx.doi.org/10.1177/0003319719825518] [PMID: 30678475]

Rights & Permissions Print Cite
Article Metrics
20
1
Wayfinder Image
Open Access Journals Promotions
World Prematurity Day
© 2024 Bentham Science Publishers | Privacy Policy